2 completed, 1 terminated. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow sucroferric oxyhydroxide: new trials by email Literature Review of sucroferric oxyhydroxide trials Research Report on sucroferric oxyhydroxide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy Tenapanor, Placebo, Phosphate Binder Agents - Hyperphosphatemia | Phase 2 / Phase 3 | Completed | Ardelyx | 236 | 2019-02-28 | 2023-03-06 |
| PA21 Safety and Efficacy in Adult Chinese Subjects PA21, sevelamer carbonate - Chronic Kidney Disease Requiring Chronic Dialysis, Hyperphosphatemia | Phase 3 | Completed | Vifor Fresenius Medical Care Renal Pharma | 286 | 2018-08-31 | 2021-06-02 |
| A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia PA21 (Velphoro®), Calcium Acetate (Phoslyra®) - Hyperphosphatemia | Phase 3 | Terminated | Vifor Fresenius Medical Care Renal Pharma | 85 | 2016-05-26 | 2019-09-10 |
Hyperphosphatemia (3) · Renal Insufficiency, Chronic (1)
Vifor Fresenius Medical Care Renal Pharma (2) · Ardelyx (1)
United States (2) · China (1) · France (1) · Germany (1) · Lithuania (1) · Poland (1) · Romania (1) · Russia (1)
David P Rosenbaum, PhD (1) · Hou Fanfan, MD (1) · Larry A Greenbaum, MD; PhD (1)